News
Cosmos Holdings enters into an Intellectual Property Sale Agreement for a formula related to prostate health
On October 1, 2016, Cosmos Holdings Inc., entered into an Intellectual Property Sale Agreement with Anastasios Tsekas and Olga Parthenea Georgatsou for the purchase of certain intellectual property rights relating to proprietary pharmaceutical formulas and any related technical information arising or related Intellectual property. The formula is related to a possible prostate health improvement and cure including prostate gland enlargement, prostate infections, prostate cancer, and other urinary problems. Cosmos Holdings is in the process of locating a specialized ...
Increased Loan Facility to $1,532,974 as a result SYNTHESIS PEER-TO-PEER INCOME FUND advancing $240,251 to Sky Pharm
On September 13, 2016, Sky Pharm S.A., a wholly owned subsidiary of Cosmos Holdings Inc., entered into a First Deed of Amendment to Loan Facility Agreement dated as of August 4, 2016 and guaranteed by Grigorios Siokas, with Synthesis Peer-To Peer-Income Fund. The Loan Facility provided Sky Pharm with a credit facility of up to $1,292,769. The Amendment increased the Loan Facility to $1,532,974 as a result of the Lender having advanced $240,251 to Sky Pharm. The ...
Cosmos Holding’s wholly owned subsidiary Sky Pharm S.A. receives $1,292,769 credit facility from Synthesis Peer-to-Peer Income Fund
On August 4, 2016, Sky Pharm S.A., a wholly owned subsidiary of Cosmos Holdings Inc., a Nevada corporation entered into a Loan Facility Agreement, guaranteed by Grigorios Siokas, Cosmos Holdings CEO, with Synthesis Peer-To Peer-Income Fund . The Loan Facility provides Sky Pharm with a credit facility of up to $1,292,769. Any advance under the Loan Facility accrues interest at a rate of 10% per annum and requires quarterly interest payments commencing on September 30, 2016. The ...
Cosmos Holdings enters into a preliminary agreement with Doc Pharma SA
On May 20, 2016, Cosmos Holdings Inc. entered into a non-binding Memorandum of Understanding with DOC Pharma SA, a company controlled by Grigorios Siokas, the Company's CEO, a director and principal shareholder. DOC Pharma SA located in Thessaloniki, Greece, is also an ISO certified and licensed GDP (Good Distribution Practices) wholesaler of pharmaceuticals. It is the owner of numerous licenses for generic medicines and uses its own network of pharmaceutical sales representatives to detail its products with doctors. The Company ...
Photo
Steve Carr Managing Director

Join our mailing list to stay up to date.

Cosmos-logo